Back to Products

Renolina-M

Linagliptin+Metformin

Indications:

Renolina-M a combination of dipeptidyl peptidase-4 (DPP-4) inhibitor and Metformin, is an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus who are

  • inadequately controlled on metformin, or
  • already controlled with the free combination of linagliptin and metformin.

Dosage & Administration:

The recommended dose is Renolina-M 2.5/ 500 or Renolina-M 2.5/ 850 twice daily with food.

How supplied:

Renolina-M 2.5/500: Each commercial box contains 30 tablets (3 X 10’s) in Alu-Alu blister pack

Renolina-M 2.5/850: Each commercial box contains 20 tablets (2 X 10’s) in Alu -Alu blister pack